Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin
Event:
ESC Congress 2016
Topic:
Atrial fibrillation (AF)
Session:
New trends in antithrombotic therapy for atrial fibrillation